CLL Tracker
CLL Tracker was first released in 2010/2011 and was completed by 330 CLL patients from around the world, the results are available at the Results Page.
Over recent years the landscape of the treatment of CLL has changed significantly. The development of novel agents and ongoing developments of combination regimens are advancing the field into a realm of new, improved, and individualized possibilities for CLL patients.
The website has been updated to comply with the General Data Protection Regulation (EU) 2016/679, the most important changes in data privacy regulations in 20 years.
Finally, the website has been upgraded to better meet the changes in technology with the increase use of smart phones and tablets.
2018/2019 Survey
To take part in the 2018/2019 survey click the link below:

 

Background

CLL Tracker has been developed to provide patients with Chronic Lymphocytic Leukaemia (CLL) with information provided by other patients who share the same condition. The data contained is actual patient specific information relating to blood results, prognostic markers, their personal experience of the different treatments and the resulting effects of these treatments.

Your Information

As we require information that is specific to you as an individual, we will only ask for that which is necessary for the function of the system, your name (or alias) and a valid email address.

Your Security

We will not under any circumstances publish your specific data or share this with any other party. We want the CLL patients that use this resource to feel fully protected.

This is an international website which is privately funded by a patient with CLL for the benefit of patients with CLL and has no commercial associations with any other organisations (medical or non-medical).